If palpitations are intermittent, ambulatory ECG monitoring such as a 24-hour Holter monitor or event recorder may be arranged to capture episodes
This weight reduction was obtained with hormones that decrease appetite and stimulate insulin sensitivity, making tirzepatide the best in obesity treatment
Both semaglutide and tirzepatide are designed for steady, sustained results rather than rapid drops, which is part of why ongoing monitoring matters
For those ready to embrace this promising approach, a collaborative, holistic plan involving both medication and lifestyle changes is essential
The SUSTAIN-6 trial (Marso et al., New England Journal of Medicine, 2016) showed a 26% reduction in major adverse cardiovascular events (MACE) with subcutaneous semaglutide vs placebo in patients with type 2 diabetes and high cardiovascular risk